Connect with us

Stock News

Obesity drugs’ next wave: These companies could snag 20% of GLP-1 market, analysts say

Published

on


While Eli Lilly and Novo Nordisk dominate the obesity-drug market, there’s a vast field of would-be competitors closing in behind them — and the most successful among those next-wave contenders stand to capture up to 20% of the lucrative market, analysts say.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stock News

Treasury yields trim declines after PCE inflation reading edges up from Fed’s target

Published

on

Treasury yields were trimming earlier declines after a barrage of pre-Thanksgiving economic data added to the case for gradual Fed rate cuts .

Continue Reading

Stock News

Jobless claims slide to 7-month low. Businesses not cutting many jobs.

Published

on


The number of Americans who applied for unemployment benefits in the week before the Thanksgiving holiday dipped to a seven-month low in a sign of strength for a steadily expanding U.S. economy.

Continue Reading

Stock News

More turnover at the top, but this bull still believes in the Weight Watchers parent

Published

on


D.A. Davidson reckons WW is a buy as its customers need more than a prescription.

Continue Reading

Trending